# 4541
For more than a week Australian public health officials have been dealing with reports of an unusual number of (seemingly) influenza vaccine related side effects among children under the age of five.
High fevers, nausea, and vomiting . . . and to a lesser extent febrile convulsions . . . appear to be the big complaints. One death, not yet officially linked to the vaccine, has been reported as well.
You’ll find earlier coverage of these events here, here, and here.
The vaccine in question is CSL’s Fluvax - a trivalent combination of seasonal and the novel H1N1 antigen - which has been primarily distributed in Australia, New Zealand, and Singapore.
To date, officials have been unable to ascertain the cause of these side-effects.
While the investigation is ongoing, Professor Nikolai Petrovsky, a Flinders University immunologist, and founder and chief executive of a rival vaccine company (Vaccine Limited), has his own theory.
He believes that high levels of RNA residue in this year’s vaccine are the cause of these adverse reactions in children; a product he claims, of a 50-year old egg-based vaccine manufacturing technology.
At this point, one should note that Professor Petrovsky is founder and promoter of a rival company that utilizes genetically modified insect cells (instead of eggs) to manufacture vaccine.
A technique he claims produces no RNA residue.
Since I’m not a scientist, I’m not qualified to embrace either side of this issue. I’ll simply pass along this excerpt from The Age, and await more learned opinions on the matter.
Residue in flu jab causing kids' reactions: scientist
GRAEME O'NEILL
May 2, 2010
A LEADING researcher claims to have identified why the seasonal flu vaccine is causing an outbreak of adverse reactions in children, including high temperatures, fits and convulsions.
Professor Nikolai Petrovsky, a Flinders University immunologist, says an experiment he carried out indicates that large amounts of viral genetic residue created by the vaccine's manufacture were overloading infants' immune systems.
The experiment left him in "absolutely no doubt" that high levels of the residue in the form of RNA (the viruses' genetic blueprint) were the cause.
Professor Petrovsky's claims were supported by Melbourne immunologist Professor Bryan Williams, whose team at the Monash Institute of Medical Research is at the forefront of research into how the immune system detects infection.
Related Post:
- Adding To A Feverish Debate
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- FDA Statement On Azithromycin & Cardiovascular Risks
- NEJM: Cardiovascular Risks Of Taking Azithromycin
- Study: PPIs & Increased Pneumonia Risk
- NSAIDs and Prior Heart Attacks
- Japan: Investigating Pediatric Vaccines
- JAMA: Cell Phone Use Stimulates Brain Activity
- Australia: Panvax Investigated For Febrile Convulsions
- EMA To Review Pandemrix Vaccine
- Finland Suspends Use of Pandemrix Vaccine
- Australia: CSL Recalls Pediatric Flu Vax
- Eurosurveillance: Adverse Effects of Oseltamivir in Children
- Australian Vaccine Investigation Widens
- Australia Investigating Adverse Vaccine Reactions
- Canada Probes Adverse Vaccine Reactions
- Hong Kong: No Increase In Fetal Death Among Vaccine Recipients
- Branswell Reports On GSK Vaccine Allergic Reactions
- Canadian Weekly Vaccine Surveillance Report
- Japan: Small Number of Adverse Vaccine Reactions
- The Double Edged Sword
- A Few Inflammatory Remarks
- The Coincidence Factor
- The Background Is Always In Motion
- Anticipating The Flu Season Down Under
- ACP Calls For Health Care Worker Immunizations
- Branswell On Flu Vaccine Matches
- Flu Vaccine Still Available, But Spot Shortages Exist
- Study: Self-Administered Vaccines In Adults
- Egypt: A Paltry Poultry Vaccine
- Lancet: Low Flu Vaccine Effectiveness
- Hong Kong: H5N1 Vaccine Recommended For Certain Lab Workers
- AAP Endorses SAGE Recommendations Keeping Thimerosal In Vaccines
- NIVW 2012
- Study Supports Safety Of Tdap Vaccine In Older Patients
- JAMA: Waning Pertussis Vaccine Effectiveness Over Time
- Revisiting The Numbers Racket
- Of Pregnancy, Flu & Autism
- Canada & Switzerland Clear Novartis Flu Vaccine For Use
- CMAJ On Mandatory Flu Shot For HCWs
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- The UK’s Whooping Cough Outbreak
- Peter Sandman On the CCIVI Vaccine Report
- CIDRAP: The Need For `Game Changing’ Flu Vaccines
- Rhode Island Adopts New Flu Vaccination Requirements For HCPs
- Vietnam Reports Progress On New Bird Flu Vaccine
- WHO: Southern Hemisphere 2013 Flu Vaccine Composition
- NPM12: Giving Preparedness A Shot In The Arm
- Yes, We Have No Pandemic . . .
- Anticipating The Flu Season Down Under
- Dr. Alan Hampson Interview On Indonesia’s New Bird Flu Clade
- NSW: Hen Facility Quarantined Under Suspicion Of Avian Influenza
- Queensland: A Hendra Watch & A New Vaccine
- CSIRO: The Quest For Flu Resistant Poultry
- The 2012 Flu Season Down Under
- CSL: Report On Febrile Reactions To FluVax
- Australia Finds LPAI H5 On Two Duck Farms
- Prof. Peter Doherty On Influenza’s Threat
- Another Yank From Oxford
- ECDC: Risk Assessment On Australia’s Antiviral Resistant H1N1 Cluster
- The Flu Season Down Under
- Australia: Dog Tests Positive For Hendra Virus
- Australia: Flu Season Nearing Peak - ISG
- MJA: Safety Of Flu Shot In Young Children
- A Sexually Transmitted Disease Cure
- Yasi Makes Landfall On Queensland Coast
- Ain’t We Got Fund?
- Australia: Panvax Investigated For Febrile Convulsions
- Australia: No Clear Answers On Child’s Death
- The Uptake Down Under
- Australia Lifts Ban On Flu Vax For Under Five’s
- Study: Pandemic Mitigation by Early School Closure
- NZ And Australia Seeing Increase In Flu-Like Illnesses
- Study: Eurosurveillance On `The Canadian Problem’
Widget by [ Iptek-4u ]